| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.8M | — | +49.7% |
| Cost of Revenue | $40.3M | — | +54.7% |
| Gross Profit | $12.4M | — | +35.3% |
| R&D Expense | $87K | — | +19.2% |
| SG&A Expense | $9.7M | — | +28.4% |
| Operating Income | $2.7M | — | +68.8% |
| Income Tax | $577K | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.4M | +22.4% | +103.2% |
| Accounts Receivable | $13.2M | +1.1% | +127.6% |
| Inventory | $9.0M | -6.7% | +70.3% |
| Current Assets | $48.8M | +8.2% | +101.3% |
| Total Assets | $87.5M | +2.1% | +66.0% |
| Current Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.0M | — | -16.6% |
| Capital Expenditures | $177K | — | -67.2% |
| Investing Cash Flow | -$177K | — | +67.2% |
| Financing Cash Flow | -$372K | — | +38.5% |
| Free Cash Flow | $4.8M | — | -11.6% |
| +106.1% |
| Net Income | $2.1M | — | +66.3% |
| EPS (Basic) | $0.05 | — | +66.7% |
| EPS (Diluted) | $0.05 | — | +66.7% |
| $21.0M |
| +1.0% |
| +12.1% |
| Total Liabilities | $32.2M | -2.8% | +22.4% |
| Stockholders' Equity | $55.4M | +5.2% | +109.4% |